» Articles » PMID: 20580604

Effects of a Probiotic Fermented Milk Beverage Containing Lactobacillus Casei Strain Shirota on Defecation Frequency, Intestinal Microbiota, and the Intestinal Environment of Healthy Individuals with Soft Stools

Overview
Journal J Biosci Bioeng
Date 2010 Jun 29
PMID 20580604
Citations 46
Authors
Affiliations
Soon will be listed here.
Abstract

The effects of drinking a fermented milk beverage that contains Lactobacillus casei strain Shirota (LcS) at 40 billion bacterial cells/bottle for 4 weeks (probiotics, 1 bottle/day) on defecation frequency, intestinal microbiota and the intestinal environment of healthy individuals with soft stools were evaluated. Thirty-four healthy adults who had soft stools were randomised into 2 groups, and the effects of a regular 4-week intake of probiotics were evaluated by a placebo-controlled, double-blind, parallel-group comparative design. Defecation frequency significantly decreased after the 4-week intake period compared with before the probiotic treatment. The stool quality significantly improved (hardened) compared to the placebo. Also, the water content of the stools was lower in the probiotic group than in the placebo group. Live LcS was recovered at 6.9 ± 1.3 and 7.2 ± 0.8 log(10) CFU per 1g of stool after 2 and 4 weeks, respectively, of probiotic treatment. The number of bifidobacteria in the stools also increased significantly compared with the level before starting the probiotics. The organic acid levels (total, acetic acid, propionic acid, and butyric acid) significantly increased compared with the level before intake in both the probiotic and placebo groups, but they returned to the original levels after the end of the intake period. These results suggest that probiotic fermented milk beverage has an intestine-conditioning effect by improving the frequency of defecation and stool quality and increasing the intrinsic bifidobacteria in healthy individuals with soft stool.

Citing Articles

Biotechnological potential of Lacticaseibacillus paracasei Shirota for bioemulsifier, bacteriocin and lipase production.

de Medeiros N, da Nobrega F, Lopes P, de Assis C, Sousa Junior F Braz J Microbiol. 2024; 55(4):3229-3238.

PMID: 39388035 PMC: 11711593. DOI: 10.1007/s42770-024-01534-4.


Synbiotic supplementation may globally improve non-motor symptoms in patients with stable Parkinson's disease: results from an open label single-arm study.

Andreozzi V, Cuoco S, Balestrieri M, Fierro F, Ferrara N, Erro R Sci Rep. 2024; 14(1):23095.

PMID: 39367119 PMC: 11452401. DOI: 10.1038/s41598-024-74400-w.


The effects of dairy on the gut microbiome and symptoms in gastrointestinal disease cohorts: a systematic review.

Ni Chonnachain C, Feeney E, Gollogly C, Shields D, Loscher C, Cotter P Gut Microbiome (Camb). 2024; 5:e5.

PMID: 39290657 PMC: 11406376. DOI: 10.1017/gmb.2024.2.


Assessing the causal effects of and on constipation: a Mendelian randomized study.

Zhang X, Chen J, He F, Du W, Yu X Front Microbiol. 2024; 15:1376232.

PMID: 39144218 PMC: 11324052. DOI: 10.3389/fmicb.2024.1376232.


Evaluating the Effect of Strain Shirota on the Physical Consistency of Stool in Healthy Participants with Hard or Lumpy Stools: A Double-Blind, Randomized, Placebo-Controlled Study.

Tsujibe S, Gawad A, Shigehisa A, Matsuda K, Fujimoto J, Takahashi T Nutrients. 2024; 16(15).

PMID: 39125350 PMC: 11313875. DOI: 10.3390/nu16152469.